BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
Artificial intelligence
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 5, 2019
View Archived Issues
Dopamine goes from pleasure to repair molecule
Read More
Broad strategy for HIV bnAbs
Read More
Gene therapy can treat, prevent heart failure
Read More
iRhom2 is fibrosis friend, not foe
Read More
FDA approves Talicia for treatment of H. pylori in adults
Read More
Harbour BioMed initiates first-in-human study of HBM-4003
Read More
Positive interim safety and efficacy data presented for OTS Allocetra
Read More
Development of novel PRKACA inhibitors for the treatment of fibrolamellar carcinoma
Read More
KYM-003, potent and selective STAT3 degrader with strong antitumor activity in vivo
Read More
Preclinical data for SNSP-113 support its development as new approach to treat mucus stasis in CF
Read More
Novartis presents phase II data for QBW-276
Read More
VRN-071961: a potent EGFR kinase inhibitor active in Ex20Ins EGFR mutation-driven NSCLC
Read More
Promising preclinical results presented for DTX-701, a gene therapy for Wilson disease
Read More
AstraZeneca initiates phase I/IIa study of AZD-7648 alone and in combination for advanced cancers
Read More
Clarivate Analytics introduces next-gen drug R&D platform: Cortellis Drug Discovery Intelligence
Read More
MedImmune initiates first-in-human study of MEDI-5395 with durvalumab in advanced solid tumors
Read More
Terns patents new MAP3K5 inhibitors
Read More
Lycera describes MAP4K1 inhibitors
Read More
Neuropore Therapies synthesizes PI3K-AKT-mTOR pathway inhibitors
Read More
Unum shifts focus to solid tumor programs
Read More
Japanese investigators patent CRF1 and CRF2 dual receptor antagonists
Read More
Morphic Therapeutic identifies new MAdCAM antagonists
Read More
FDA clears IND for Compugen's COM-902
Read More
Halozyme Therapeutics to halt development of PEGPH20 following phase III results
Read More
FDA approves influenza vaccine Fluzone High-Dose Quadrivalent
Read More